PD Dr. Thomas Weissmann

Department of Radiation Oncology

Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients (2022) Weissmann T, Rückert M, Zhou J, Seeling M, Lettmaier S, Donaubauer AJ, Nimmerjahn F, et al. Journal article Highlights from the 2021 ASCO and ESMO annual meetings on radiotherapy of head and neck cancer Highlights der ASCO- und ESMO-Jahrestagungen 2021 zur Strahlentherapie von Kopf-Hals-Tumoren (2022) Hecht M, von der Grün J, Semrau S, Müller S, Weissmann T, Gaipl U, Iro H, et al. Journal article, Review article Extracranial temporal bone paragangliomas: Re-defining the role of otologic surgery within the scope of function-preserving multimodal concepts (2022) Mantsopoulos K, Thimsen V, Eisenhut F, Weissmann T, Putz F, Fietkau R, Iro H, et al. Journal article Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites? (2021) Weissmann T, Höfler D, Hecht M, Semrau S, Haderlein M, Filimonova I, Frey B, et al. Journal article Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors (2021) Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, et al. Journal article Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial (2021) Donaubauer AJ, Becker I, Weissmann T, Fröhlich B, Munoz LE, Gryc T, Denzler M, et al. Journal article Reduction of elective radiotherapy treatment volume in definitive treatment of locally advanced head and neck cancer—comparison of a prospective trial with a revised simulated contouring approach (2021) Weissmann T, Speer S, Putz F, Lettmaier S, Schubert P, Shariff M, Semrau S, et al. Journal article Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells (2021) Wimmer S, Deloch L, Hader M, Derer A, Grottker F, Weissmann T, Hecht M, et al. Journal article Experience gained with Durvalumab Maintenance Therapy after definitive Chemoradiotherapy in Patients with NSCLC: Survival- and Toxicity Data from Routine clinical Practice (2021) Lettmaier S, Hecht M, Weissmann T, Fietkau R Conference contribution High Detection Accuracy of an optimized 3D Convolutional Neural Network for Auto Detection and Auto Segmentation of Brain Metastases (2021) Putz F, Weissmann T, Mansoorian S, Schmitter C, Semrau S, Lettmaier S, Masitho S, et al. Conference contribution